Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. (Q35925244)
Jump to navigation
Jump to search
scientific article published on 5 March 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. |
scientific article published on 5 March 2012 |
Statements
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24 (English)
D Craig Allred
Soonmyung Paik
D Lawrence Wickerham
Elefetherios P Mamounas
Thomas B Julian
Charles E Geyer
Joseph P Costantino
Stephanie R Land
Norman Wolmark
1 reference
1 reference
1 reference
1 reference
1 reference